Cornell teams join NSF campaign for cybersecurity

Six Cornell researchers will receive grants totaling more than $3 million as part of the National Science Foundation Secure and Trustworthy Cyberspace program.

Obesity leads to 'silent' vitamin A deficiency in organs

Obesity impairs the body’s ability to use vitamin A appropriately and leads to deficiencies of the vitamin in major organs, according to new research conducted at Weill Cornell Medicine.

New drug combo suggests promising lymphoma treatment

Weill Cornell Medicine finds a combination therapy lacking many debilitating effects manages mantle cell lymphoma, shrinking the malignancy and inducing remissions in most patients.

Cornell Tech Runway Program accepting postdoc applications

The Runway Startup Postdoc Program – described as "part business school, part research institution, part startup incubator" – is designed to advance the participants' research and launch new business ventures.

Vitamin C halts aggressive colorectal cancer: study

High levels of vitamin C kill certain kinds of colorectal cancers in cell cultures and mice, according to a new study from Weill Cornell Medicine investigators.

New type of cancer treatment targets cancer cell proteins

Weill Cornell Medicine researchers have found a new therapeutic approach to an aggressive form of lymphoma that may greatly increase the efficacy of treatment and result in better patient outcomes.

Real estate contest draws record number of applicants

The School of Hotel Administration’s seventh annual Cornell International Real Estate Case Competition will feature 20 teams of undergraduates compete for prize money Nov. 9-10 in New York City.

Provost tackles 'the challenge and art' of charting the future

Michael I. Kotlikoff discusses his role as the university's chief academic officer, the strategic planning process he will lead for Cornell and how his experience as a dean has prepared him for this job.

Poultry vaccine nets Ezra Technology Innovator Award

Two Cornell professors emeriti of veterinary medicine have received the 2015 Ezra Technology Innovator Award for their work as co-inventors of the Marek's disease vaccine.